Please use this identifier to cite or link to this item:
Title: Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3
Authors: Liakina, V
Hamid, S
Tanaka, J
Olafsson, S
Sharara, A I
Alavian, S M
Gheorghe, L
El Hassan, E S
Abaalkhail, F
Abbas, Z
Abdou, A
Abourached, A
Al Braiki, F
Al Hosani, F
Al Jaberi, K
Al Khatry, M
Al Mulla, M A
Al Quraishi, H
Al Rifai, A
Al Serkal, Y
Alam, A
Alashgar, H I
Alawadhi, S
Al-Dabal, L
Aldins, P
Alfaleh, F Z
Alghamdi, A S
Al-Hakeem, R
Aljumah, A A
Almessabi, A
Alqutub, A N
Alswat, K A
Altraif, I
Alzaabi, M
Andrea, N
Assiri, A M
Babatin, M A
Baqir, A
Barakat, M T
Bergmann, O M
Bizri, A R
Blach, S
Chaudhry, A
Choi, M S
Diab, T
Djauzi, S
El Khoury, S
Estes, C
Fakhry, S
Farooqi, J I
Fridjonsdottir, H
Gani, R A
Ghafoor Khan, A
Goldis, A
Gottfredsson, M
Gregorcic, S
Hajarizadeh, B
Han, K H
Hasan, I
Hashim, A
Horvath, G
Hunyady, B
Husni, R
Jafri, W
Jeruma, A
Jonasson, J G
Karlsdottir, B
Kim, D Y
Kim, Y S
Koutoubi, Z
Lesmana, L A
Lim, Y S
Löve, A
Maimets, M
Makara, M
Malekzadeh, R
Matičič, M
Memon, M S
Merat, S
Mokhbat, J E
Mourad, F H
Muljono, D H
Nawaz, A
Nugrahini, N
Priohutomo, S
Qureshi, H
Rassam, P
Razavi, H
Razavi-Shearer, D
Razavi-Shearer, K
Rozentale, B
Sadik, M
Saeed, K
Salamat, A
Salupere, R
Sanai, F M
Sanityoso Sulaiman, A
Sayegh, R A
Schmelzer, J D
Sibley, A
Siddiq, M
Siddiqui, A M
Sigmundsdottir, G
Sigurdardottir, B
Speiciene, D
Sulaiman, A
Sultan, M A
Taha, M
Tarifi, H
Tayyab, G
Tolmane, I
Ud Din, M
Umar, M
Valantinas, J
Videčnik-Zorman, J
Yaghi, C
Yunihastuti, E
Yusuf, M A
Zuberi, B F
Gunter, J
Affiliations: Faculty of Medicine 
Keywords: Diagnosis
Disease burden
Hepatitis C
Hepatitis C virus
Issue Date: 2015
Part of: Journal of Viral Hepatitis
Volume: 22
Start page: 4
End page: 20
Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.
ISSN: 13520504
DOI: 10.1111/jvh.12475
Ezproxy URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record


checked on Jun 3, 2023

Record view(s)

checked on Jun 9, 2023

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.